Searching the Resource Information Network

Our searching services are busy right now. Please try again later

  • Register
X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X

Leaving Community

Are you sure you want to leave this community? Leaving the community will revoke any permissions you have been granted in this community.

No
Yes

A homozygous frameshift mutation in the mouse Flg gene facilitates enhanced percutaneous allergen priming.

Padraic G Fallon | Takashi Sasaki | Aileen Sandilands | Linda E Campbell | Sean P Saunders | Niamh E Mangan | John J Callanan | Hiroshi Kawasaki | Aiko Shiohama | Akiharu Kubo | John P Sundberg | Richard B Presland | Philip Fleckman | Nobuyoshi Shimizu | Jun Kudoh | Alan D Irvine | Masayuki Amagai | W H Irwin McLean
Nature genetics | 2009

Loss-of-function mutations in the FLG (filaggrin) gene cause the semidominant keratinizing disorder ichthyosis vulgaris and convey major genetic risk for atopic dermatitis (eczema), eczema-associated asthma and other allergic phenotypes. Several low-frequency FLG null alleles occur in Europeans and Asians, with a cumulative frequency of approximately 9% in Europe. Here we report a 1-bp deletion mutation, 5303delA, analogous to common human FLG mutations, within the murine Flg gene in the spontaneous mouse mutant flaky tail (ft). We demonstrate that topical application of allergen to mice homozygous for this mutation results in cutaneous inflammatory infiltrates and enhanced cutaneous allergen priming with development of allergen-specific antibody responses. These data validate flaky tail as a useful model of filaggrin deficiency and provide experimental evidence for the hypothesis that antigen transfer through a defective epidermal barrier is a key mechanism underlying elevated IgE sensitization and initiation of cutaneous inflammation in humans with filaggrin-related atopic disease.

Pubmed ID: 19349982

Research resources used in this publication

None found

Antibodies used in this publication

None found

Associated grants

  • Agency: NIAMS NIH HHS, United States
    Id: R01 AR049183
  • Agency: NIAMS NIH HHS, United States
    Id: R01 AR49183
  • Agency: NIAMS NIH HHS, United States
    Id: R01 AR049183-01
  • Agency: Medical Research Council, United Kingdom
    Id: G0700314
  • Agency: NIADDK NIH HHS, United States
    Id: P01 AM21557
  • Agency: NIAMS NIH HHS, United States
    Id: R01 AR049183-02

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

This is a list of tools and resources that we have found mentioned in this publication.


MacVector (tool)

RRID:SCR_015700

Software application that provides sequence editing, primer design, internet database searching, protein analysis, sequence confirmation, multiple sequence alignment, phylogenetic reconstruction, coding region analysis, agarose gel simulation and a variety of other functions.

View all literature mentions

C57BL/6J (tool)

RRID:IMSR_JAX:000664

Mus musculus with name C57BL/6J from IMSR.

View all literature mentions

C57BL/6J (tool)

RRID:IMSR_JAX:000664

Mus musculus with name C57BL/6J from IMSR.

View all literature mentions